Patellofemoral disorders Chondromalacia patellae Patellofemoral Pain Syndrome Women
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women; Aged between 18 and 40 years; Clinical diagnosis of patellofemoral pain (PFP); Unilateral or bilateral symptoms; History of anterior knee pain for at least three months; Worsening pain in at least two PFP-related activities, such as climbing and descending stairs, jumping, kneeling, sitting for a long period; Pain on palpation of the medial or lateral facet of the patella.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Women with any degree of osteoarthritis; History of previous surgery on the spine, hips, knees, ankle or foot; History of patellar instability or patellar dislocation (traumatic or atraumatic); History of a previous ligament or meniscal injury; Sensibility to the material used to apply the Kinesio Taping method.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the Kujala Anterior Knee Pain Scale at the end of treatment (6 weeks), which is expected to detect an average difference of 8 points between groups (Minimally Clinically Important Difference). The Kujala questionnaire will be applied at the baseline, at the third week of the treatment protocol, at the end of treatment (6 weeks) and at the 12-week follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will be the numeric pain rating scale (NPRS) at rest and during effort, the Lower Extremity Functional Scale (LEFS) questionnaire, the WHOQOL-bref questionnaire, and the Global Rating Changing Scale (GRCS) (a 10 cm visual analogue scale on which there will be a phrase "no improvement" at the left extremity and the phrase "totally recovered" at the right extremity. The numerical pain scale at rest and during effort, the LEFS questionnaire and the WHOQOL-bref questionnaire will be applied at the baseline, at the third week of the treatment protocol, at the end of treatment (6 weeks) and at 12-week follow-up. The GRCS will be applied at the end of treatment (sixth week). | — |
Countries
Brazil
Contacts
Instituto de Assistência Médica ao Servidor Público Estadual